| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |